BioRestorative Therapies, Inc. (BRTX)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | — | ||
| 10-KLatest | FY-2025 | — | ||
| 10-Q | Q3-2025 | 8-K (2025-11-12) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-12) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-14) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-03-27) · 99.1 | 8-K (2024-11-13) · 99.1 · 99.2 · 99.3 | ||
| 10-Q | Q3-2024 | — | ||
| 10-K/A | FY-2023 | |||
| 10-Q | Q2-2024 | 8-K (2024-08-13) · 99.1 | 8-K (2024-08-06) · 99.1 | ||
| 10-K/A | FY-2023 | |||
| 10-Q | Q1-2024 | — | ||
| 10-K | FY-2023 | — | ||
| 10-Q | Q3-2023 | — | ||
| 10-Q | Q2-2023 | — |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | ||
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations | ||
| Consolidated Statements of Changes In Stockholders' Equity | ||
| Consolidated Statements of Changes In Stockholders' Equity (P) | ||
| Consolidated Statements of Cash Flows | ||
| Consolidated Statements of Cash Flows (P) | ||
| Notes | ||
| Accrued Expenses and Other Current Liabilities | ||
| Basis of Presentation and Summary of Significant Accounting Policies | — |
|
| Business Organization, Nature of Operations, Basis of Presentation and Liquidity | — |
|
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Fair Value Measurement | ||
| Income Taxes | — |
|
| Insider Trading Arrangements | — |
|
| Insider Trading Policies and Procedures | — |
|
| Intangible Assets | ||
| Leases | ||
| Nature of The Organization, Liquidity, and Business | — |
|
| Notes Payable | — |
|
| Organization, Liquidity and Business Operations | — |
|
| Organization, Liquidity, Going Concern and Business Operations | — |
|
| Pay Vs Performance Disclosure | — |
|
| Property and Equipment | — |
|
| Stockholders Equity | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||